Back
Speaker illustration

Doctor Federica Guidetti

Inselspital - University of Bern, Bern (Switzerland)

Member of:

European Society of Cardiology
Heart Failure Association

Federica is an advanced heart failure specialist with a deep passion for heart failure research and treatment. She began her training in Italy under the mentorship of Professor Marco Metra, where she developed her expertise in the field. After being awarded a prestigious ESC grant, he moved to Zurich, where she worked with Thomas Lusher and Frank Ruschitzka to further specialize in advanced heart failure. Driven by a commitment to research, she started a PhD at the Karolinska Institute under the main supervision of Gianluigi Svarese and Lars Lund , focusing on heart failure outcomes through his work with the Swedish Heart Failure Registry. She has returned to Switzerland and is currently an advanced heart failure specialist at Bern University Hospital. In addition to his clinical and research activities, Federica is multilingual and enjoys biking and surfing as well as every kind of sport.

Presentations

Refining definitions of severe and advanced heart failure: insight from the swedish heart failure registry to optimize trial design and improve referral to advanced therapies

Event: Heart Failure 2025

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Advances in heart failure therapeutics

Access
Like
Thumbnail

HFpEF management comparison between HF-cardiologists, non-HF-cardiologists and other specialties: an international survey

Event: Heart Failure 2024

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Management of heart failure in real world

Access
Like
Thumbnail

Cardiac amyloidosis awareness comparison between HF-cardiologists, non-HF-cardiologists and other specialties around the world: insights from international survey

Event: Heart Failure 2024

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure - pathophysiology and mechanisms 2

Access
Like
Thumbnail

Safety of continuing mineralocorticoid receptor antagonists treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: data from swedish heart failure registry

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Pharmacotherapy

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources